David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 293



111
112
TITLE: Patients with Sarcopenia Benefit from Neoadjuvant Chemotherapy in Advanced Ovarian Cancer  Full Text
AUTHORS: L.B Conrad; Schmidt, S; A.A Bailey; Carlson, M; Kehoe, S; Richardson, D; David Scott Miller ; J.S Lea;
PUBLISHED: 2017, SOURCE: Gynecologic Oncology, VOLUME: 147, ISSUE: 1
INDEXED IN: CrossRef
IN MY: ORCID
113
TITLE: Response to “Towards implementation of sexual healthcare”
AUTHORS: Sarah Bedell; Dustin Manders; David Scott Miller ; Jayanthi Lea; Siobhan Kehoe; Debra Richardson; Matthew Carlson;
PUBLISHED: 2017, SOURCE: Gynecologic Oncology Reports, VOLUME: 20
INDEXED IN: Scopus CrossRef
IN MY: ORCID
114
TITLE: Sparse feature selection for classification and prediction of metastasis in endometrial cancer  Full Text
AUTHORS: Mehmet Eren Ahsen; Todd P Boren; Nitin K Singh; Burook Misganaw; David G Mutch; Kathleen N Moore; Floor J Backes; Carolyn K McCourt; Jayanthi S Lea; David Scott Miller ; Michael A White; Mathukumalli Vidyasagar;
PUBLISHED: 2017, SOURCE: BMC Genomics, VOLUME: 18, ISSUE: S3
INDEXED IN: Scopus CrossRef: 18
IN MY: ORCID
115
TITLE: Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol  Full Text
AUTHORS: William T Creasman; Shamshad Ali; David G Mutch; Richard J Zaino; Matthew A Powell; Robert S Mannel; Floor J Backes; Paul A DiSilvestro; Peter A Argenta; Michael L Pearl; Shashikant B Lele; Saketh R Guntupalli; Steven Waggoner; Nick Spirtos; John F Boggess; Robert P Edwards; Virginia L Filiaci; David Scott Miller ;
PUBLISHED: 2017, SOURCE: Gynecologic Oncology, VOLUME: 145, ISSUE: 3
INDEXED IN: Scopus CrossRef: 51
IN MY: ORCID
116
TITLE: The opinions and practices of providers toward the sexual issues of cervical cancer patients undergoing treatment  Full Text
AUTHORS: Sarah Bedell; Dustin Manders; Siobhan Kehoe; Jayanthi Lea; David Scott Miller ; Debra Richardson; Matthew Carlson;
PUBLISHED: 2017, SOURCE: Gynecologic Oncology, VOLUME: 144, ISSUE: 3
INDEXED IN: Scopus CrossRef: 8
IN MY: ORCID
117
TITLE: Weekly paclitaxel for recurrent ovarian cancer: Does weekly administration during primary therapy impact efficacy and toxicity at recurrence?  Full Text
AUTHORS: C.C Gunderson; Papaila, A; Ding, K; A.M Jernigan; Bedell, S; David Scott Miller ; D.M Barnes; K.N Moore;
PUBLISHED: 2017, SOURCE: Gynecologic Oncology, VOLUME: 145
INDEXED IN: CrossRef
IN MY: ORCID
118
TITLE: Core muscle index is prognostic of survival in advanced ovarian cancers  Full Text
AUTHORS: L.B Conrad; Awdeh, H; A.A Bailey; David Scott Miller ; J.S Lea;
PUBLISHED: 2016, SOURCE: Gynecologic Oncology, VOLUME: 143, ISSUE: 1
INDEXED IN: CrossRef: 1
IN MY: ORCID
119
TITLE: Factors influencing primary treatment of midline vulvar cancers  Full Text
AUTHORS: Lesley B Conrad; Steven A Conrad; David Scott Miller ; Debra L Richardson; Siobhan Kehoe; Jayanthi S Lea;
PUBLISHED: 2016, SOURCE: Gynecologic Oncology, VOLUME: 142, ISSUE: 1
INDEXED IN: Scopus CrossRef
IN MY: ORCID
120
TITLE: Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis  Full Text
AUTHORS: Kathleen N Moore; James J Java; Katrina N Slaughter; Peter G Rose; Rachelle Lanciano; Paul A DiSilvestro; Tate T Thigpen; Yi Chun Lee; Krishnansu S Tewari; Junzo Chino; Shelly M Seward; David Scott Miller ; Ritu Salani; David H Moore; Frederick B Stehman;
PUBLISHED: 2016, SOURCE: Gynecologic Oncology, VOLUME: 143, ISSUE: 2
INDEXED IN: Scopus CrossRef: 28
IN MY: ORCID
Page 12 of 30. Total results: 293.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service